Research Papers

25 of 48 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Mutations of TRPM8 channels: Unraveling the molecular basis of activation by cold and ligands.
Plaza-Cayón A; González-Muñiz R; Martín-Martínez M.
Med Res Rev (Unknown)
Published: 2022
3/6 Transparent
Data Funding Declared
Biofabrication approaches and regulatory framework of metastatic tumor-on-a-chip models for precision oncology.
Nieto D; Jiménez G; Moroni L; López-Ruiz E; Gálvez-Martín P; Marchal JA.
Med Res Rev (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Skin cancer, including related pathways and therapy and the role of luteolin derivatives as potential therapeutics.
Juszczak AM; Wöelfle U; Končić MZ; Tomczyk M.
Med Res Rev (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Cardiovascular therapeutics: A new potential for anxiety treatment?
Repova K; Aziriova S; Krajcirovicova K; Simko F.
Med Res Rev (Unknown)
Published: 2022
2/6 Transparent
Funding Declared
β3-Adrenoceptor, a novel player in the round-trip from neonatal diseases to cancer: Suggestive clues from embryo.
Filippi L; Pini A; Cammalleri M; Bagnoli P; Dal Monte M.
Med Res Rev (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Upgrade of an old drug: Auranofin in innovative cancer therapies to overcome drug resistance and to increase drug effec…
Gamberi T; Chiappetta G; Fiaschi T; Modesti A; Sorbi F; Magherini F.
Med Res Rev (Unknown)
Published: 2021
1/6 Transparent
Funding Declared
Mechanism of activation and the rewired network: New drug design concepts.
Nussinov R; Zhang M; Maloney R; Tsai CJ; Yavuz BR; Tuncbag N; Jang H.
Med Res Rev (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
The lymphatic vasculature: An active and dynamic player in cancer progression.
Rezzola S; Sigmund EC; Halin C; Ronca R.
Med Res Rev (Unknown)
Published: 2021
1/6 Transparent
Funding Declared
Pharmaceuticals targeting signaling pathways of endometriosis as potential new medical treatment: A review.
Hung SW; Zhang R; Tan Z; Chung JPW; Zhang T; Wang CC.
Med Res Rev (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Discovery of K<sub>V</sub> 1.3 ion channel inhibitors: Medicinal chemistry approaches and challenges.
Gubič Š; Hendrickx LA; Toplak Ž; Sterle M; Peigneur S; Tomašič T; Pardo LA; Tytgat J; Zega A; Mašič LP.
Med Res Rev (Unknown)
Published: 2021
3/6 Transparent
Data Funding Declared
Artificial intelligence and machine learning-aided drug discovery in central nervous system diseases: State-of-the-arts…
Vatansever S; Schlessinger A; Wacker D; Kaniskan HÜ; Jin J; Zhou MM; Zhang B.
Med Res Rev (Unknown)
Published: 2020
2/6 Transparent
Code Funding Declared
Understanding the tumor microenvironment for effective immunotherapy.
Sadeghi Rad H; Monkman J; Warkiani ME; Ladwa R; O'Byrne K; Rezaei N; Kulasinghe A.
Med Res Rev (Unknown)
Published: 2020
1/6 Transparent
Funding Declared
Molecular targeting therapies for neuroblastoma: Progress and challenges.
Zafar A; Wang W; Liu G; Wang X; Xian W; McKeon F; Foster J; Zhou J; Zhang R.
Med Res Rev (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Evolution of the adaptogenic concept from traditional use to medical systems: Pharmacology of stress- and aging-related…
Panossian AG; Efferth T; Shikov AN; Pozharitskaya ON; Kuchta K; Mukherjee PK; Banerjee S; Heinrich M; Wu W; Guo DA; Wagner H.
Med Res Rev (Unknown)
Published: 2020
1/6 Transparent
Inhibitors of bromodomain and extra-terminal proteins for treating multiple human diseases.
Kulikowski E; Rakai BD; Wong NCW.
Med Res Rev (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Medicinal chemistry strategies toward host targeting antiviral agents.
Ji X; Li Z.
Med Res Rev (Unknown)
Published: 2020
1/6 Transparent
Funding Declared
Tumor-derived exosomes (TDEs): How to avoid the sting in the tail.
Wan M; Ning B; Spiegel S; Lyon CJ; Hu TY.
Med Res Rev (Unknown)
Published: 2019
1/6 Transparent
Funding Declared
The role of integrins in the pathogenesis of inflammatory bowel disease: Approved and investigational anti-integrin the…
Dotan I; Allez M; Danese S; Keir M; Tole S; McBride J.
Med Res Rev (Unknown)
Published: 2019
2/6 Transparent
Funding Declared
Lipoprotein-associated phospholipase A2: The story continues.
Huang F; Wang K; Shen J.
Med Res Rev (Unknown)
Published: 2019
1/6 Transparent
Funding Declared
Norovirus antivirals: Where are we now?
Netzler NE; Enosi Tuipulotu D; White PA.
Med Res Rev (Unknown)
Published: 2018
2/6 Transparent
Funding Declared
Recent clinical trends in Toll-like receptor targeting therapeutics.
Anwar MA; Shah M; Kim J; Choi S.
Med Res Rev (Unknown)
Published: 2018
2/6 Transparent
Funding Declared
Hunting for the high-affinity state of G-protein-coupled receptors with agonist tracers: Theoretical and practical cons…
Shalgunov V; van Waarde A; Booij J; Michel MC; Dierckx RAJO; Elsinga PH.
Med Res Rev (Unknown)
Published: 2018
1/6 Transparent
Funding Declared
Involvement of calpain in the neuropathogenesis of Alzheimer's disease.
Mahaman YAR; Huang F; Kessete Afewerky H; Maibouge TMS; Ghose B; Wang X.
Med Res Rev (Unknown)
Published: 2018
2/6 Transparent
Funding Declared
Avenues to molecular imaging of dying cells: Focus on cancer.
Rybczynska AA; Boersma HH; de Jong S; Gietema JA; Noordzij W; Dierckx RAJO; Elsinga PH; van Waarde A.
Med Res Rev (Unknown)
Published: 2018
Recent progress in the antiviral activity and mechanism study of pentacyclic triterpenoids and their derivatives.
Xiao S; Tian Z; Wang Y; Si L; Zhang L; Zhou D.
Med Res Rev (Unknown)
Published: 2018
1/6 Transparent
Funding Declared